Home Latest Articles
Latest Articles
  • Ziyang XU, Jun TAN, Min DENG, Lizhi CHEN, Zhuo WANG
    World Clinical Drug. 2022, 43(6): 793-798.

    Sleep deprivation (SD) causes significant impairment of attentional capacity in humans. The evaluation of SD impairment of attention and its intervention drugs and measures often requires pilot studies of SD and the use of attention testing tools to evaluate the effect of different SD conditions on a person's attention. It is necessary to comprehensively consider the advantages and disadvantages of different methods and select appropriate attention testing tools. This article reviewed the literature on the effects of SD on attention in recent years, summarized and classified the relevant attention testing tools, analyzed the characteristics of different instruments in drug trials of SD interventions, and to provide ideas for the selection of test methods in the evaluation of attention tests.

  • Lihong XU, Han LI, Yuan ZHANG, Yaping LI, Shuangsuo DANG
    World Clinical Drug. 2022, 43(6): 799-805.
    Objective

    To optimize the management of subject visits in clinical trials of drugs for chronic liver disease, meet the requirements of epidemic prevention and control, and reduce the risk of infection during the epidemic of corona virus disease 2019 (COVID-19).

    Methods

    A total of 103 subjects with chronic liver disease who underwent drug clinical trials in department of infectious disease, the second affiliated hospital of Xi'an Jiaotong university were enrolled from 5 December 2019 to 6 December 2020. Clinical data including gender, age, education level, clinical drug research experience, completion of visit and adverse reactions were analyzed, and the coping strategies of liver disease subjects at this stage were put forward according to the possible influencing factors.

    Results

    During the epidemic of COVID-19, 1 329 subjects were planned to visit, 1 329 subjects were completed (100%), and 1 318 subjects were returned to the hospital (99.17%). Among them, 2 subjects were visited by out of time visits (0.15%). Eleven subjects were allowed to visit hospitals near their place of residence (0.83%). A total of 47 subjects had adverse reactions (3.54%), and no one infected with COVID-19.

    Conclusion

    During the prevention and control of the COVID-19 epidemic, classified visit management should be implemented according to the visit plan of drug clinical trials to strengthen the communication and coordination between researchers and subjects, protect the rights and interests of subjects, reduce the risk of COVID-19 infection, and ensure the smooth implementation of the research projects.

  • Hongyan MA, Xiao ZHOU, Lin YU, Jing LI, Huizhu SONG
    World Clinical Drug. 2022, 43(6): 806-810.

    In order to effectively improve the detection rate of irrational medical orders, comprehensively and individually ensure clinical rational drug use and promote the safety of inpatients' medication use, the pre-audit system--medical intelligent and decision system (MINDs) of routine inpatient medical orders, was refined and revised and supplemented. This article discussed the effect of refined setting of pre-audit system rules on rational use of drug and average drug cost per hospitalization after the selection and dosage of perioperative prevention surgery with antibacterial drug, the selection of special class of antimicrobial agents, the usage and dosage of drugs under different indications, the selection of drugs for patients with renal insufficiency, drug interaction, blood drug concentration monitoring warning and discharge medication from hospital.

  • Haiming SHI
    World Clinical Drug. 2022, 43(5): 489-491.

    Chronic heart failure (CHF) is the final stage of various heart diseases, which seriously affects the quality of life and life of patients. At present, the main drugs for CHF include angiotensin converting enzyme inhibitor, β-blocker and aldosterone receptor antagonists, while other new drugs have been developed. Traditional Chinese medicine has its unique advantages in the treatment of CHF. This paper reviewed the treatment of CHF with integrated traditional Chinese and western medicine, in order to provide reference for clinical treatment.

  • Zhuojin LI, Yunjing SHI, Wei JIN
    World Clinical Drug. 2022, 43(5): 492-496.

    Heart failure with mid-range ejection fraction (HFmrEF) entered the academic field for the first time as a new classification of heart failure (HF) in 2016. With the development of relevant research in this field, the 2021 European Society of Cardiology and 2022 American Heart Association/American College of Cardiology/American Heart Failure Society new HF guidelines redefined it as heart failure with mildly reduced ejection fraction (HFmrEF). The name change reveals the understanding of HFmrEF has entered a new era. This paper reviewed the epidemiology, clinical characteristics, prognosis and treatment of HFmrEF.

  • Weiguo WEI, Feng WU, Min FAN
    World Clinical Drug. 2022, 43(5): 497-502.

    Traditional Chinese medicine has been widely used in the treatment of chronic heart failure (CHF), with increasingly obvious advantages. In addition to conventional drug therapy, non-drug therapies such as acupuncture, massage and rehabilitation have also made great progress in the treatment of CHF, with significant effect, fewer adverse reactions and high degree of patient cooperation, which are worthy of popularization and application. This article reviewed the application of acupuncture, massage and rehabilitation therapies in the treatment of CHF.

  • Shihui HONG, Feng WU, Min FAN
    World Clinical Drug. 2022, 43(5): 503-508.

    Heart failur (HF) is a severe manifestation or advanced stage of various heart diseases, with high mortality and re-hospitalization rates. The prevalence of HF continues to increase in China. According to “China Cardiovascular Health and Disease Report 2020”, there are 8.9 million HF patients in China, and the mortality rate is also increasing year by year. Heart transplant is still the best option for patients with advanced HF, but the lack of donors greatly affects treatment decision making and patient management. Therefore, efficient and safe alternative therapies are urgently needed. This paper reviewed the recent research and clinical application of mechanical assisted circulatory devices as an alternative therapy before heart transplantation.

  • Jingfen XING, Feng WU, Min FAN
    World Clinical Drug. 2022, 43(5): 509-513.

    Heart failure (HF) is a global cardiovascular disease, which brings economic burden to the health care system. Transthoracic echocardiography is widely used in clinical diagnosis of acute and chronic HF, but the echocardiography is greatly affected by patient's position, and also faces many problems and challenges. With the development of artificial intelligence technology, robots collect echocardiographic images instead of sonographers, and the development of fully automated three-dimensional ultrasound quantization software for right ventricle is expected to achieve more efficient and accurate diagnosis in clinical practice.

  • Qiyuan MAO, Lanchun LIU, Ruijuan CAI, Surui YUAN, Huiling ZHOU, Yulin KUANG, Daorui LI, Hongsheng LIN
    World Clinical Drug. 2022, 43(5): 514-522.
    Objective

    To explore the potential mechanism of active components of Sophora flavescens in acute myeloid leukemia (AML) based on network pharmacology.

    Methods

    We searched Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform, and the effective active components and corresponding targets of Sophora flavescens were screened. The AML action targets were obtained by GeneCards database, and the intersection targets of drugs and diseases were obtained. Cytoscape3.7.2 software was used to construct the interaction network diagram of drug effective active components, targets and diseases. The protein-protein interaction (PPI) network is constructed with the help of STRING database, analyzed with R software, and then the network diagram is drawn with Cytoscape3.7.2 software, gene ontology biological process (GO-BP) functional enrichment analysis and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis were performed on the intersection targets.

    Results

    A total of 45 active components of Sophora flavescens were screened and matched, including 99 targets, 1 549 AML related targets, 64 drug disease intersection targets and 22 active components. 62 PPI core genes were screened. GO-BP function enrichment analysis showed that the target was mainly involved in the degradation of ubiquitin protein ligase, the apoptosis process with cysteine endopeptidase activity, the binding of activating transcription factors, the binding of nuclear hormone receptors and other biological processes. KEGG pathway enrichment showed that Sophora flavescens was mainly involved in the formation of proteoglycan, phosphatidylinositol-3-kinase serine/Akt kinase, tumor necrosis factor and human tumor suppressor gene p53 in cancer. It also provided a certain reference for exploring the multi-channel and multi-target mechanism of Sophora flavescens in the treatment of AML.

    Conclusion

    Sophora flavescens has the characteristics of multi-component, multi-target and multi-channel in the treatment of AML, which also provides a certain reference for further exploring the therapeutic effect and related mechanism of traditional Chinese medicine on AML.

  • Mao WANG, Yinhai DAI, Hong LI, Zhihui ZHOU, Yuanyuan LI, Fuping LI, Rui CHENG, Shangpeng LI
    World Clinical Drug. 2022, 43(5): 523-532.
    Objective

    To investigate the effect of Spalt-like transcription factor 4 (SALL4) on adriamycin (ADR) resistance of breast cancer cells and its regulation mechanism.

    Methods

    Quantitative reverse transcriptase-mediated polymerase chain reaction (qRT-PCR) and western blot (WB) were used to detect the expression of SALL4 in breast cancer cell lines. SALL4-silenced breast cancer drug resistant cell line short hairpin RNA (shRNA)-SALL4 macrophage chemotactic factor (MCF)-7/ADR was constructed and the effects of SALL4 on cell proliferation activity, half inhibitory concentration (IC50) and apoptosis rate were detected by cell proliferation assay and flow cytometry. The effect of SALL4 on the expression of gene of phosphate and tension homology deleted on chromsome ten (PTEN), key genes of PTEN/protein kinase B (PKB)/mammalian target of rapamycin (mTOR) pathway and cell resistance genes were detected, respectively.

    Results

    The messenger RNA (mRNA) and protein levels of SALL4 in breast cancer cell lines were significantly higher than those in normal breast cell lines (P<0.05). The IC50 value of shRNA-SALL4 MCF-7/ADR group was significantly decreased, the proliferation activity was decreased, and the apoptosis rate was significantly increased. The expression of drug resistance genes ABCB1, C-myc and ABCG2 were significantly decreased (P<0.05). The expression of PTEN in shRNA-SALL4 MCF-7/ADR group was significantly increased, and the expression of p-PKB and p-mTOR were significantly decreased (P<0.05). There was no significant change in apoptosis rate and expression level of drug-resistant genes in shRNA-SALL4 MCF-7/ADR group after ADR treatment with PTEN inhibitor.

    Conclusions

    SALL4 may enhance the proliferation of breast cancer cells and inhibit cell death through the PTEN/PKB/mTOR pathway, reverse the process of ADR resistance to some extent.

News